Publications by authors named "Maria Perry"

Claim this Profile
P
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial.
Wungki Park, Catherine O'Connor, Joanne Chou, Marc Hilmi, Zeynep Tarcan, Maria Perry

Res Sq· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype.
Marta Clariano, Diogo Nunes, Daniela Canudo, Daniela Maçãs, Bruno J L Castro, Maria de Jesus Perry

ACS Med Chem Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort.
Fergus Keane, Catherine O'Connor, Drew Moss, Joanne F Chou, Maria A Perry

J Natl Cancer Inst· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer.
Mark Zucker, Maria A Perry, Samuel I Gould, Arielle Elkrief, Anton Safonov

Cell· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.
Anna M Varghese, Maria A Perry, Joanne F Chou, Subhiksha Nandakumar, Daniel Muldoon

Nat Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. 2021, , 5289.
Sara R Oliveira, Pedro A Dionísio, Maria M Gaspar, Maria B T Ferreira, Catarina A B Rodrigues, Maria J Perry

Int J Mol Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitroaromatic-based triazene prodrugs to target the hypoxic microenvironment in glioblastoma.
Cláudia Braga, Margarida Ferreira-Silva, M Luísa Corvo, Rui Moreira, Alexandra R Fernandes, Maria J Perry

RSC Med Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated real-world data integration improves cancer outcome prediction.
Justin Jee, Christopher Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra, Maria Perry

Nature· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors.
Joana Gonçalves, Joana D Amaral, Rita Capela, Maria de Jesus Perry, Cláudia Braga

Cell Death Discov· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma.
Jacinta O Pinho, Mariana Matias, Ana Godinho-Santos, Joana D Amaral, Eduarda Mendes, Maria Jesus Perry

Int J Pharm· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target Identification in Anti-Tuberculosis Drug Discovery.
Rita Capela, Rita Félix, Marta Clariano, Diogo Nunes, Maria de Jesus Perry

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management.
Jacinta O Pinho, Mariana Matias, Vanda Marques, Carla Eleutério, Célia Fernandes, Maria Jesus Perry

Biomed Pharmacother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma.
Margarida Granada, Eduarda Mendes, Maria Jesus Perry, Maria João Penetra, Maria Manuela Gaspar

ACS Med Chem Lett· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.
Sara R Oliveira, Pedro A Dionísio, Maria M Gaspar, Maria B T Ferreira, Catarina A B Rodrigues, Maria J Perry

Int J Mol Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism of N-ethylhexedrone and buphedrone: An in vivo study in mice using HPLC-MS/MS.
Joana Carrola, Noélia Duarte, Pedro Florindo, Sara Henriques, Gustavo da Silva, Maria de Jesus Perry

J Chromatogr B Analyt Technol Biomed Life Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Triazenes: from Bioprecursors to Hybrid Molecules.
Ana P Francisco, Eduarda Mendes, Ana R Santos, Maria J Perry

Curr Pharm Des· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability.
Cláudia Braga, Ana R Vaz, M Conceição Oliveira, M Matilde Marques, Rui Moreira, Maria J Perry

Eur J Med Chem· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability.
Rita Capela, Joana Magalhães, Daniela Miranda, Marta Machado, Margarida Sanches-Vaz, Maria J Perry

Eur J Med Chem· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The selective cytotoxicity of new triazene compounds to human melanoma cells.
Ana Sousa, Fábio Santos, Maria Manuela Gaspar, Susana Calado, João D Pereira, Maria Jesus Perry

Bioorg Med Chem· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?
Rui Pinheiro, Cláudia Braga, Gisela Santos, Maria R Bronze, Maria J Perry

ACS Chem Neurosci· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian analyses demonstrate tissue blood volume is not decreased during acute sickle cell pain episodes: A preliminary study.
Maria Perry, Jena Simon, Daniel Gareau, Jeffrey Glassberg

Clin Hemorheol Microcirc· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From hybrid compounds to targeted drug delivery in antimalarial therapy.
Rudi Oliveira, Daniela Miranda, Joana Magalhães, Rita Capela, Maria J Perry

Bioorg Med Chem· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.
Catarina A B Rodrigues, Raquel F M Frade, Inês S Albuquerque, Maria J Perry, Jiri Gut

ChemMedChem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and discovery of mushroom tyrosinase inhibitors and their therapeutic applications.
Eduarda Mendes, Maria de Jesus Perry, Ana Paula Francisco

Expert Opin Drug Discov· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards an efficient prodrug of the alkylating metabolite monomethyltriazene: synthesis and stability of N-acylamino acid derivatives of triazenes.
Maria de Jesus Perry, Emília Carvalho, Eduarda Rosa, Jim Iley

Eur J Med Chem· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis